Alzheimer's: FDA delays approval for Eli Lilly’s donanemab
Share on PinterestThe FDA is currently reviewing the drug donanemab for early Alzheimer’s treatment....
FDA issues final decision to withdraw approval of Pepaxto (melphalan flufenamide)
Pepaxto Update [2/23/2024] Today, FDA announced its final decision to withdraw approval of Pepaxto (melphalan...
Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti
Share on PinterestThe FDA has approved brexpiprazole for treating agitation in dementia. josemoraes/Getty...